Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin

BACKGROUND: Simeprevir with peginterferon and ribavirin has been used for the treatment of chronic hepatitis caused by genotype 1 hepatitis C virus (HCV). We explored the predictive factors for sustained virological response (SVR) and viral relapse using datasets from four Japanese phase 3 studies (...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepatol Int
Hlavní autoři: Nakayama, Masahiko, Kobayashi, Hisanori, Fukushima, Koji, Ishido, Miwako, Komada, Yuji, Yoshizawa, Kazutake
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer India 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722076/
https://ncbi.nlm.nih.gov/pubmed/26264253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-015-9654-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky